| Entry |
|
|---|
| Name |
Furethidine (INN) |
|---|
| Formula |
C21H31NO4
|
|---|
| Exact mass |
361.2253
|
|---|
| Mol weight |
361.4751
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Comment |
Phenylpiperidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
D12682 Furethidine
Analgesic
DG01984 Opioid analgesics
D12682 Furethidine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D12682 Furethidine (INN)
Narcotics and psychotropics in Japan [br08308.html]
Narcotics by Control Act Article 2 Table 1 (74 substances)
D12682
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C8x C 19.6237 -14.0870
2 C8y C 19.6237 -15.4887
3 C8x C 20.8151 -16.1895
4 C8x C 22.0066 -15.4887
5 C8x C 22.0066 -14.0870
6 C8x C 20.8151 -13.3862
7 C1z C 18.3622 -16.1895
8 C1x C 17.1707 -15.5588
9 C1x C 15.9793 -16.2596
10 N1y N 15.9793 -17.6613
11 C1x C 17.1707 -18.2921
12 C1x C 18.3622 -17.5912
13 C1b C 14.7178 -18.3622
14 C7a C 19.0630 -17.4511
15 O7a O 20.5348 -17.4511
16 O6a O 18.3622 -18.6425
17 C1b C 21.1655 -18.6425
18 C1a C 22.6373 -18.6425
19 C1b C 14.7178 -19.7622
20 O2a O 13.5053 -20.4622
21 C1b C 12.2929 -19.7622
22 C1y C 11.0805 -20.4622
23 C1x C 9.7761 -19.8817
24 C1x C 8.8210 -20.9428
25 C1x C 9.5351 -22.1791
26 O2x O 10.9315 -21.8820
BOND 28
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 1
14 10 13 1
15 7 14 1
16 14 15 1
17 14 16 2
18 15 17 1
19 17 18 1
20 13 19 1
21 19 20 1
22 20 21 1
23 21 22 1
24 22 23 1
25 23 24 1
26 24 25 1
27 25 26 1
28 22 26 1
|
|---|
